2031년까지 글로벌 및 남아프리카 암 치료제 시장 전망

Global & South Africa Cancer Therapeutics Market to 2031

상품코드Slovakia Cancer Therapeutics Market.pdf
발행기관Business Market Insights
발행일2025.05.26
페이지 수100 Pages
포맷PDF
커버리지Country

₩3,600,000 – ₩6,600,000

보고서 요약(국문)

중동 및 아프리카의 주요 경제국 중 하나인 남아프리카공화국은 2023년 약 3,777억 8천만 달러의 GDP를 기록했습니다. 의료비 지출은 GDP의 약 8.5%를 차지하며, 국가 지출에서 두 번째로 큰 비중을 차지합니다. 정부와 민간 부문 모두 의료 인프라 개선을 위한 투자를 늘리고 있으며, 이에 따라 치료 솔루션에 대한 수요도 증가하고 있습니다. 아프리카에서 가장 선진적인 의료 시스템을 보유한 남아프리카공화국은 암 연구 및 치료 혁신에 지속적으로 상당한 투자를 하고 있습니다. 고령화, 의료 서비스 접근성 향상, 진단 도구의 발전과 같은 요인들이 효과적인 암 치료법에 대한 필요성을 증대시키고 있습니다.

암은 남아프리카공화국의 주요 사망 원인 중 하나이며, 유방암, 전립선암, 자궁경부암, 폐암이 가장 흔합니다. GLOBOCAN 2020에 따르면, 남아프리카공화국에서는 그해 약 108,168건의 새로운 암 환자가 발생했고 56,802명이 암 관련 사망에 이르렀습니다. 증가하는 암 발병률에 대응하여 남아프리카공화국 정부는 치료 접근성을 확대하고 치료법 발전을 지원하는 전략을 적극적으로 시행하고 있습니다. 이러한 전략은 암 예방, 조기 발견, 그리고 환자 예후 개선을 위한 치료 선택권 확대에 중점을 두고 있습니다. 또한 암 치료 서비스를 강화하기 위한 국가 보건 정책도 도입되었습니다. 예를 들어, 제안된 국민건강보험(NHI) 제도는 모든 시민에게 암 치료를 포함한 포괄적인 의료 보장을 제공함으로써 필수적이고 잠재적으로 생명을 구할 수 있는 치료에 대한 접근성을 확대하는 것을 목표로 합니다.

보고서 요약(영어 원문)

South Africa, one of the leading economies in the Middle East and Africa, recorded a GDP of approximately US$377.78 billion in 2023. Healthcare spending represents around 8.5% of the country’s GDP, making it the second-largest component of national expenditure. With both government and private sector investments increasing to enhance healthcare infrastructure, there is a growing demand for therapeutic solutions. As home to one of Africa’s most advanced healthcare systems, South Africa continues to invest significantly in cancer research and treatment innovations. Factors such as an aging population, improved access to medical services, and advancements in diagnostic tools are driving the need for effective cancer therapies.

Cancer is among the primary causes of mortality in South Africa, with breast, prostate, cervical, and lung cancers being the most prevalent. According to GLOBOCAN 2020, the country reported approximately 108,168 new cancer cases and 56,802 cancer-related deaths that year. In response to the rising cancer burden, the South African government is actively implementing strategies aimed at expanding access to care and supporting therapeutic advancements. These strategies focus on cancer prevention, early detection, and enhancing treatment options to improve patient outcomes. National health policies have also been introduced to strengthen cancer care services. For example, the proposed National Health Insurance (NHI) scheme aims to deliver comprehensive healthcare coverage to all citizens, including cancer treatments, thereby facilitating broader access to essential and potentially life-saving therapies.

상세 목차

TABLE OF CONTENTS

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation:

4. South Africa Cancer Therapeutics Market Landscape

4.1 Overview

4.2 Ecosystem Analysis

4.2.1 List of Vendors in the Value Chain

5. Cancer Therapeutics Market Key Market Dynamics

5.1 Cancer Therapeutics Market – Key Market Dynamics

5.2 Market Drivers

5.3 Market Restraints

5.4 Market Opportunities

5.5 Future Trends

5.6 Impact of Drivers and Restraints

6. South Africa Cancer Therapeutics Market – Analysis

6.1 South Africa Cancer Therapeutics Market Revenue (US$ Million), 2021–2031

6.2 South Africa Cancer Therapeutics Market Revenue and Forecast Analysis

7. South Africa Cancer Therapeutics Market Analysis – by Therapy Types

7.1 South Africa Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Therapy Types

8. South Africa Cancer Therapeutics Market Analysis – by Indications

8.1 South Africa Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Indications

9. South Africa Cancer Therapeutics Market Analysis – by Distribution Channel

9.1 South Africa Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Distribution Channel

10. Competitive Landscape

10.1 Heat Map Analysis by Key Players

10.1 Company Positioning and Concentration

11. Industry Landscape

11.1 Overview

11.2 Market Initiative

11.2 Partnerships and Collaborations

11.2 Other Developments

12. Company Profiles

12.1 Bristol-Myers Squibb Co

12.1. 1 Key Facts

12.1. 2 Business Description

12.1. 3 Products and Services

12.1. 4 Financial Overview

12.1. 5 SWOT Analysis

12.1. 6 Key Developments

12.2 AbbVie Inc

12.2. 1 Key Facts

12.2. 2 Business Description

12.2. 3 Products and Services

12.2. 4 Financial Overview

12.2. 5 SWOT Analysis

12.2. 6 Key Developments

12.3 Johnson & Johnson

12.3. 1 Key Facts

12.3. 2 Business Description

12.3. 3 Products and Services

12.3. 4 Financial Overview

12.3. 5 SWOT Analysis

12.3. 6 Key Developments

12.4 F. Hoffmann-La Roche Ltd

12.4. 1 Key Facts

12.4. 2 Business Description

12.4. 3 Products and Services

12.4. 4 Financial Overview

12.4. 5 SWOT Analysis

12.4. 6 Key Developments

12.5 Pfizer Inc

12.5. 1 Key Facts

12.5. 2 Business Description

12.5. 3 Products and Services

12.5. 4 Financial Overview

12.5. 5 SWOT Analysis

12.5. 6 Key Developments

12.6 AstraZeneca Plc

12.6. 1 Key Facts

12.6. 2 Business Description

12.6. 3 Products and Services

12.6. 4 Financial Overview

12.6. 5 SWOT Analysis

12.6. 6 Key Developments

12.7 Merck KGaA

12.7. 1 Key Facts

12.7. 2 Business Description

12.7. 3 Products and Services

12.7. 4 Financial Overview

12.7. 5 SWOT Analysis

12.7. 6 Key Developments

12.8 Novartis AG

12.8. 1 Key Facts

12.8. 2 Business Description

12.8. 3 Products and Services

12.8. 4 Financial Overview

12.8. 5 SWOT Analysis

12.8. 6 Key Developments

12.9 Astellas Pharma Inc

12.9. 1 Key Facts

12.9. 2 Business Description

12.9. 3 Products and Services

12.9. 4 Financial Overview

12.9. 5 SWOT Analysis

12.9. 6 Key Developments

12.10 Eli Lilly and Co

12.10. 1 Key Facts

12.10. 2 Business Description

12.10. 3 Products and Services

12.10. 4 Financial Overview

12.10. 5 SWOT Analysis

12.10. 6 Key Developments

13. Appendix

13.1 About Business Market Insights

13.2 List of Abbreviations

언급된 주요 기업들

TABLE OF COMPANIES

1. Bristol-Myers Squibb Co

2. AbbVie Inc

3. Johnson & Johnson

4. F. Hoffmann-La Roche Ltd

5. Pfizer Inc

6. AstraZeneca Plc

7. Merck KGaA

8. Novartis AG

9. Astellas Pharma Inc

10. Eli Lilly and Co

표 목록 (Tables)

TABLE OF TABLES

Table 1. South Africa Cancer Therapeutics Market Segmentation

Table 2. List of Vendors

Table 3. South Africa Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million)

Table 4. South Africa Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million)

Table 5. South Africa Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Therapy Types

Table 6. South Africa Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy Types

Table 7. South Africa Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Indications

Table 8. South Africa Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications

Table 9. South Africa Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel

Table 10. South Africa Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel

Table 11. List of Abbreviations

그림 목록 (Figures)

TABLE OF FIGURES

Figure 1. Impact Analysis of Drivers and Restraints

Figure 2. South Africa Cancer Therapeutics Market Revenue, (US$ Million), 2021–2031

Figure 3. Heat Map Analysis by Key Players

Figure 4. Company Positioning and Concentration